Literature DB >> 12200414

Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons.

Donato Goffredo1, Dorotea Rigamonti, Marzia Tartari, Alberto De Micheli, Claudia Verderio, Michela Matteoli, Chiara Zuccato, Elena Cattaneo.   

Abstract

Huntington's disease (HD) is caused by a polyglutamine expansion in the amino-terminal region of huntingtin. Mutant huntingtin is proteolytically cleaved by caspases, generating amino-terminal aggregates that are toxic for cells. The addition of calpains to total brain homogenates also leads to cleavage of wild-type huntingtin, indicating that proteolysis of mutant and wild-type huntingtin may play a role in HD. Here we report that endogenous wild-type huntingtin is promptly cleaved by calpains in primary neurons. Exposure of primary neurons to glutamate or 3-nitropropionic acid increases intracellular calcium concentration, leading to loss of intact full-length wild-type huntingtin. This cleavage could be prevented by calcium chelators and calpain inhibitors. Degradation of wild-type huntingtin by calcium-dependent proteases thus occurs in HD neurons, leading to loss of wild-type huntingtin neuroprotective activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200414     DOI: 10.1074/jbc.C200353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

2.  BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.

Authors:  H Jourdi; L Hamo; T Oka; A Seegan; M Baudry
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

Review 3.  The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.

Authors:  Julie Leegwater-Kim; Jang-Ho J Cha
Journal:  NeuroRx       Date:  2004-01

4.  Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.

Authors:  Tamara Ratovitski; Ekaterine Chighladze; Elaine Waldron; Ricky R Hirschhorn; Christopher A Ross
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

5.  Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.

Authors:  Chansik Hong; Hyemyung Seo; Misun Kwak; Jeha Jeon; Jihoon Jang; Eui Man Jeong; Jongyun Myeong; Yu Jin Hwang; Kotdaji Ha; Min Jueng Kang; Kyu Pil Lee; Eugene C Yi; In-Gyu Kim; Ju-Hong Jeon; Hoon Ryu; Insuk So
Journal:  Brain       Date:  2015-06-30       Impact factor: 13.501

Review 6.  Studying polyglutamine diseases in Drosophila.

Authors:  Zhen Xu; Antonio Joel Tito; Yan-Ning Rui; Sheng Zhang
Journal:  Exp Neurol       Date:  2015-08-06       Impact factor: 5.330

Review 7.  Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases.

Authors:  A Cristina Rego; Catarina R Oliveira
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 8.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

9.  Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.

Authors:  Tie-Shan Tang; Huiping Tu; Edmond Y W Chan; Anton Maximov; Zhengnan Wang; Cheryl L Wellington; Michael R Hayden; Ilya Bezprozvanny
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

10.  Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.

Authors:  Tamara Ratovitski; Marjan Gucek; Haibing Jiang; Ekaterine Chighladze; Elaine Waldron; James D'Ambola; Zhipeng Hou; Yideng Liang; Michelle A Poirier; Ricky R Hirschhorn; Rona Graham; Michael R Hayden; Robert N Cole; Christopher A Ross
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.